Cargando…
Anticoagulation therapy in COVID-19 patients with chronic kidney disease
Coagulopathy and derangements in the coagulation parameters are significant features of COVID-19 infection, which increases the risk of disseminated intravascular coagulation, thrombosis, and hemorrhage in these patients, resulting in increased morbidity and mortality. In times of COVID-19, special...
Autores principales: | Shafiee, Mohammad Ali, Hosseini, Sayyideh Forough, Mortazavi, Mojgan, Emami, Anahita, Mojtahed Zadeh, Mahtab, Moradi, Sanaz, Shaker, Pouyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506255/ https://www.ncbi.nlm.nih.gov/pubmed/34729071 http://dx.doi.org/10.4103/jrms.JRMS_875_20 |
Ejemplares similares
-
Diagnostic and prognostic value of Sepsis-Induced coagulopathy and International Society on Thrombosis and Hemostasis scoring systems in COVID-19-associated disseminated intravascular coagulopathy
por: Hosseini, Sayyideh Forough, et al.
Publicado: (2021) -
Survival of Post-Transplant Lymphoproliferative Disorder after Kidney Transplantation in Patients under Rapamycin Treatment
por: Ashrafi, Farzaneh, et al.
Publicado: (2021) -
The Impact of Hemodialysis Frequency and Duration on Blood Pressure Management and Quality of Life in End-Stage Renal Disease Patients
por: Shafiee, Mohammad Ali, et al.
Publicado: (2017) -
White Matter Tract Alterations in Drug-Naïve Parkinson’s Disease Patients With Impulse Control Disorders
por: Mojtahed Zadeh, Mahtab, et al.
Publicado: (2018) -
Effects of Oral L-Carnitine Supplementation on Lipid Profile, Anemia, and Quality of Life in Chronic Renal Disease Patients under Hemodialysis: A Randomized, Double-Blinded, Placebo-Controlled Trial
por: Emami Naini, Afsoon, et al.
Publicado: (2012)